Tata Elxsi Q3FY26 Revenue Rises to Rs 9.54 Billion
ECONOMY & POLICY

Tata Elxsi Q3FY26 Revenue Rises to Rs 9.54 Billion

Tata Elxsi reported steady growth in the third quarter of FY26, with operating revenue reaching Rs 9.54 billion for the period ended December 31, 2025, reflecting a quarter-on-quarter increase of 3.9 per cent.

Earnings before interest, tax, depreciation and amortisation stood at Rs 2.22 billion, translating into an EBITDA margin of 23.3 per cent. Profit before tax rose 12.7 per cent quarter-on-quarter to Rs 2.42 billion, while profit after tax increased 15.7 per cent to Rs 1.79 billion, excluding a one-time exceptional item linked to the new labour code.

Growth during the quarter was led by the transportation business, driven by accelerated ramp-ups in software-defined vehicle programmes with original equipment manufacturers and the normalisation of workstreams with a strategic OEM client impacted in the previous quarter. The company also secured a new programme with a US-based off-highway OEM for the development of a complex operator information and control system, reinforcing its turnkey system and software development capabilities integrated with human–machine interface and human-centric design.

From a regional perspective, Europe and the US delivered broad-based growth across key accounts and verticals. While the media and communications, as well as healthcare and life sciences segments, were affected by seasonal furloughs and delayed deal closures, the company expects recovery and renewed growth in both verticals from the fourth quarter.

In healthcare, investments in generative artificial intelligence-powered regulatory workflows resulted in a multi-year, multi-million deal with a European MedTech leader to transform regulatory processes and improve cycle times and quality. The company also won a significant contract for a next-generation drug delivery system for critical illness treatment, highlighting its strength in innovation-led product engineering.

In the telecom space, Tata Elxsi was selected as a strategic partner by a major European telecom operator for a three-year network transformation programme aimed at enabling autonomous networks. The engagement will leverage NEURON, the company’s platform for orchestration and automation across 4G and 5G networks.

Operational efficiency improved during the quarter, with EBITDA rising by 220 basis points quarter-on-quarter, supported by better utilisation and delivery excellence. The company continues to invest in applying artificial intelligence and generative AI across innovation and product engineering workflows, with increasing adoption reflected in recent deal wins.

Management said Tata Elxsi enters the final quarter of the financial year with confidence in its design-led and AI-enabled engineering capabilities, supported by new customer additions, large deal wins, continued investments in future technologies and a strong deal pipeline.

Tata Elxsi reported steady growth in the third quarter of FY26, with operating revenue reaching Rs 9.54 billion for the period ended December 31, 2025, reflecting a quarter-on-quarter increase of 3.9 per cent. Earnings before interest, tax, depreciation and amortisation stood at Rs 2.22 billion, translating into an EBITDA margin of 23.3 per cent. Profit before tax rose 12.7 per cent quarter-on-quarter to Rs 2.42 billion, while profit after tax increased 15.7 per cent to Rs 1.79 billion, excluding a one-time exceptional item linked to the new labour code. Growth during the quarter was led by the transportation business, driven by accelerated ramp-ups in software-defined vehicle programmes with original equipment manufacturers and the normalisation of workstreams with a strategic OEM client impacted in the previous quarter. The company also secured a new programme with a US-based off-highway OEM for the development of a complex operator information and control system, reinforcing its turnkey system and software development capabilities integrated with human–machine interface and human-centric design. From a regional perspective, Europe and the US delivered broad-based growth across key accounts and verticals. While the media and communications, as well as healthcare and life sciences segments, were affected by seasonal furloughs and delayed deal closures, the company expects recovery and renewed growth in both verticals from the fourth quarter. In healthcare, investments in generative artificial intelligence-powered regulatory workflows resulted in a multi-year, multi-million deal with a European MedTech leader to transform regulatory processes and improve cycle times and quality. The company also won a significant contract for a next-generation drug delivery system for critical illness treatment, highlighting its strength in innovation-led product engineering. In the telecom space, Tata Elxsi was selected as a strategic partner by a major European telecom operator for a three-year network transformation programme aimed at enabling autonomous networks. The engagement will leverage NEURON, the company’s platform for orchestration and automation across 4G and 5G networks. Operational efficiency improved during the quarter, with EBITDA rising by 220 basis points quarter-on-quarter, supported by better utilisation and delivery excellence. The company continues to invest in applying artificial intelligence and generative AI across innovation and product engineering workflows, with increasing adoption reflected in recent deal wins. Management said Tata Elxsi enters the final quarter of the financial year with confidence in its design-led and AI-enabled engineering capabilities, supported by new customer additions, large deal wins, continued investments in future technologies and a strong deal pipeline.

Next Story
Infrastructure Urban

Tanfac Industries Inks 7-year Fluorochemicals Supply Deal with Japan

Tanfac Industries has signed a long-term supply contract with a Japanese customer for the supply of fluorinated chemicals, strengthening its presence in the global specialty chemicals market and enhancing long-term revenue visibility.Under the agreement, the company will supply around 7,500 metric tonnes per annum of fluorinated chemicals, with an estimated contract value of Rs 3.37 billion per year. The total value of the contract is approximately Rs 23.62 billion over a seven-year period. The agreement is scheduled to come into effect from January 1, 2027, and is backed by committed volumes,..

Next Story
Infrastructure Urban

HGS Launches AMLens to Speed up AML Probes with Explainable AI

HGS, a leading provider of digital experience, business process management and digital media services, has launched AMLens, an AI-powered solution designed to accelerate and modernise Anti-Money Laundering (AML) investigations for financial institutions. Listed on both BSE and NSE, the company said AMLens enables faster, more accurate case resolution while helping banks meet increasingly stringent regulatory requirements.AMLens combines machine learning and Natural Language Processing (NLP) to address persistent industry challenges such as manual case handling, alert fatigue and fragmented dat..

Next Story
Infrastructure Urban

Kings Infra Charts ‘Way Forward’ Roadmap for Sustainable Value Growth

Kings Infra Ventures has outlined a refined strategic roadmap, titled “The Way Forward”, aimed at consolidating its market position and accelerating long-term value creation. Anchored in the vision of its Founder-Chairman and Managing Director, Late Shaji Baby John, the strategy focuses on financial consolidation, core business growth and unlocking institutional value from infrastructure and real estate assets.To drive effective execution, the company has adopted a decentralised corporate structure under which each business vertical functions as an independent profit centre. These vertical..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Open In App